Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis

被引:239
作者
Kaplan, M
Hayek, T
Raz, A
Coleman, R
Dornfeld, L
Vaya, J
Aviram, M [1 ]
机构
[1] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Lipid Res Lab, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Anat & Cell Biol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Galilee Technol Ctr, Lab Nat Cpds Med Use, IL-10200 Kyriat Shmona, Israel
关键词
pomegranate; lipid peroxidation; LDL; HDL; macrophages; antioxidants; atherosclerosis;
D O I
10.1093/jn/131.8.2082
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Inhibition of lipid peroxidation contributes to the attenuation of macrophage cholesterol accumulation, foam-cell formation and atherosclerosis. Evidence suggests that nutritional antioxidants such as pomegranate juice (PJ) can contribute to the reduction of oxidative stress and atherogenesis. The goals of the present study were to determine whether such beneficial effects of PJ exist when supplemented to apolipoprotein E-deficient (E degrees) mice with advanced atherosclerosis and to analyze the antiatherosclerotic activity of a tannin-fraction isolated from PJ. Mice (4-mo-old) were supplemented with PJ in their drinking water for 2 mo and compared with age-matched placebo-treated mice, as well as to young (4-mo-old) control mice, for their mouse peritoneal macrophage (MPM) oxidative state, cholesterol flux and mice atherosclerotic lesion size. PJ supplementation reduced each of the proatherogenic variables determined in the present study compared with age-matched placebo-treated mice. It significantly induced serum paraoxonase activity and reduced MPM lipid peroxide content compared with placebo-treated mice and control mice. PJ administration to E degrees mice significantly reduced the oxidized (Ox)-LDL MPM uptake by 31% and MPM cholesterol esterification and increased macrophage cholesterol eff lux by 39% compared with age-matched, placebo-treated mice. PJ consumption reduced macrophage Ox-LDL uptake and cholesterol esterification to levels lower than those in 4-mo-old, unsupplemented controls. PJ supplementation to E degrees mice with advanced atherosclerosis reduced the lesion size by 17% compared with placebo-treated mice. In a separate study, supplementation of young (2-mo-old) E degrees mice for 2 mo with a tannin fraction isolated from PJ reduced their atherosclerotic lesion size, paralleled by reduced plasma lipid peroxidation and decreased Ox-LDL MPM uptake. PJ supplementation to mice with advanced atherosclerosis reduced their macrophage oxidative stress, their macrophage cholesterol flux and even attenuated the development of atherosclerosis. Moreover, a tannin-fraction isolated from PJ had a significant antiatherosclerotic activity.
引用
收藏
页码:2082 / 2089
页数:8
相关论文
共 49 条
  • [1] Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice
    Arnal, JF
    Castano, C
    Maupas, E
    Mugniot, A
    Darblade, B
    Gourdy, P
    Michel, JB
    Bayard, F
    [J]. ATHEROSCLEROSIS, 2001, 155 (02) : 291 - 295
  • [2] LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants
    Aviram, M
    Fuhrman, B
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 188 (1-2) : 149 - 159
  • [3] PLATELET SECRETORY PRODUCTS INCREASE LOW-DENSITY-LIPOPROTEIN OXIDATION, ENHANCE ITS UPTAKE BY MACROPHAGES, AND REDUCE ITS FLUIDITY
    AVIRAM, M
    DANKNER, G
    BROOK, JG
    [J]. ARTERIOSCLEROSIS, 1990, 10 (04): : 559 - 563
  • [4] PLASMA-LIPOPROTEIN SEPARATION BY DISCONTINUOUS DENSITY GRADIENT ULTRA-CENTRIFUGATION IN HYPERLIPOPROTEINEMIC PATIENTS
    AVIRAM, M
    [J]. BIOCHEMICAL MEDICINE, 1983, 30 (01): : 111 - 118
  • [5] LESIONED LOW-DENSITY-LIPOPROTEIN IN ATHEROSCLEROTIC APOLIPOPROTEIN E-DEFICIENT TRANSGENIC MICE AND IN HUMANS IS OXIDIZED AND AGGREGATED
    AVIRAM, M
    MAOR, I
    KEIDAR, S
    HAYEK, T
    OIKNINE, J
    BAREL, Y
    ADLER, Z
    KERTZMAN, V
    MILO, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (02) : 501 - 513
  • [6] Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities
    Aviram, M
    Hardak, E
    Vaya, J
    Mahmood, S
    Milo, S
    Hoffman, A
    Billicke, S
    Draganov, D
    Rosenblat, M
    [J]. CIRCULATION, 2000, 101 (21) : 2510 - 2517
  • [7] Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
  • [8] Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R
    Aviram, M
    Billecke, S
    Sorenson, R
    Bisgaier, C
    Newton, R
    Rosenblat, M
    Erogul, J
    Hsu, C
    Dunlop, C
    La Du, B
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) : 1617 - 1624
  • [9] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [10] Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis
    Aviram, M
    Fuhrman, B
    [J]. ATHEROSCLEROSIS, 1998, 137 : S45 - S50